Share This Author
Natural history of progression after PSA elevation following radical prostatectomy.
Several clinical parameters help predict the outcomes of men with PSA elevation after radical prostatectomy, and these data may be useful in the design of clinical trials, the identification of men for enrollment into experimental protocols, and counseling men regarding the timing of administration of adjuvant therapies.
Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer.
Serum PSA level, PSA density, and needle biopsy pathologic findings are accurate predictors of tumor extent and it may be reasonable to follow up some patients whose tumors are most likely insignificant with serial PSA measurements and repeated biopsies.
The development of human benign prostatic hyperplasia with age.
Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy.
NCCN clinical practice guidelines in oncology: prostate cancer.
Natural History of Progression After PSA Elevation Following Radical Prostatectomy
Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial.
Mendelian inheritance of familial prostate cancer.
- B. Carter, T. Beaty, G. Steinberg, B. Childs, P. Walsh
- MedicineProceedings of the National Academy of Sciences…
- 15 April 1992
Evidence is provided that prostate cancer is inherited in Mendelian fashion in a subset of families and provide a foundation for gene mapping studies of heritable prostate cancer.
Radical prostatectomy versus watchful waiting in early prostate cancer.
- P. Walsh
- MedicineJournal of Urology
- 1 October 2005
The absolute reduction in the risk of death after 10 years is small, but the reductions in the risks of metastasis and local tumor progression are substantial.